切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2016, Vol. 12 ›› Issue (06) : 694 -698. doi: 10.3877/cma.j.issn.1673-5250.2016.06.014

所属专题: 文献

论著

不同治疗方法对宫颈妊娠的疗效分析
张焱1,(), 王景美2, 张姝1   
  1. 1. 210008南京大学医学院附属鼓楼医院妇产科
    2. 210008南京大学医学院附属鼓楼医院病理科
  • 收稿日期:2016-08-04 修回日期:2016-10-17 出版日期:2016-12-01
  • 通信作者: 张焱

Therapeutic effect analysis of different treatment methods on cervical pregnancy

Yan Zhang1,(), Jingmei Wang2, Shu Zhang1   

  1. 1. Department of Gynecology and Obstetrics, Nanjing Drum Tower Hospital, Affiliated Hospital of Nanjing University Medical College, Nanjing 210008, Jiangsu Province, China
    2. Department of Pathology, Nanjing Drum Tower Hospital, Affiliated Hospital of Nanjing University Medical College, Nanjing 210008, Jiangsu Province, China
  • Received:2016-08-04 Revised:2016-10-17 Published:2016-12-01
  • Corresponding author: Yan Zhang
  • About author:
    Corresponding author: Zhang Yan, Email:
引用本文:

张焱, 王景美, 张姝. 不同治疗方法对宫颈妊娠的疗效分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2016, 12(06): 694-698.

Yan Zhang, Jingmei Wang, Shu Zhang. Therapeutic effect analysis of different treatment methods on cervical pregnancy[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2016, 12(06): 694-698.

目的

探讨不同治疗方法对宫颈妊娠的疗效。

方法

选择2010年1月至2015年12月,南京大学医学院附属鼓楼医院收治的26例宫颈妊娠患者的临床病历资料为研究对象。按照患者接受的治疗方法不同,将其分为A组[n=6,采用甲氨蝶呤(MTX)+米非司酮药物治疗后,再进行清宫术治疗],B组[n=6,采用子宫动脉栓塞(UAE)治疗后,再进行清宫术治疗]和C组(n=14,直接采用清宫术治疗)。采用回顾性分析方法收集3组患者的一般临床资料、术中及术后情况等,并进行统计学分析。

结果

①3组患者的年龄、停经时间、流产次数、阴道分娩次数、术前血清β-人绒毛膜促性腺激素(hCG)水平及孕囊长度、宽度、高度等一般临床资料比较,差异均无统计学意义(P>0.05)。②A、B、C组患者术中出血量分别为(36.7±16.3)mL、(64.2±46.2)mL、(180.0±124.4)mL,3组比较,差异有统计学意义(F=5.978,P=0.008),并且A、B组患者术中出血量均低于C组患者,差异亦均有统计学意义(P<0.05)。3组患者住院时间、术后血清β-hCG水平比较,差异均无统计学意义(P>0.05)。③A、B组无一例患者进行子宫切除术,C组14例患者中,2例患者因术中出血量过高,进行子宫切除术。

结论

对于宫颈妊娠,应根据患者个体情况选择不同治疗方案,在挽救患者生命的同时尽可能保留其生育功能。MTX+米非司酮,并辅以清宫术,是安全、有效的宫颈妊娠治疗方案。

Objective

To evaluate the therapeutic effects of different treatment methods on cervical pregnancy.

Methods

A total of 26 cervical pregnancy patients′ clinical data in Nanjing Drum Tower Hospital, Affiliated Hospital of Nanjing University Medical College from January 2010 to December 2015 were selected as research subjects. According to the different treatment methods, all patients were divided into 3 groups: group A (n=6) who received methotrexate (MTX) and mifepristone combined with abortion treatment, group B (n=6) who received uterine arteries embolism (UAE) combined with abortion and group C (n=14) who received abortion treatment only. The basic clinical data, intraoperative and post-operative results were collected by retrospective method and analyzed by statistical methods.

Results

①There were no significant differences among three groups in the aspects of age, amenorrhea duration, abortion times, vaginal deliveries, preoperative β-human chorionic gonadotrophin (hCG) level, and the length, width and height of the gestational sac (P>0.05). ②The intraoperative blood loss volume in group A, B and C was (36.7±16.3) mL, (64.2±46.2) mL and (180.0±124.4) mL, respectively, and there was significant difference among three groups in intraoperative blood loss volume (F=5.978, P=0.008), and both the intraoperative blood loss volume in group A and group B were lower than that in group C, and both the differences were significantly different (P<0.05). But there were no significant differences in hospitalization time and postoperative β-hCG level among three groups (P>0.05). ③None of the patients in group A and B received hysterectomy treatment, while 2 patients in group C received hysterectomy treatment due to the high intraoperative blood loss volume among 14 patients.

Conclusions

As to cervical pregnancy, the choice of treatment method should be based on the patient′s conditions, in order to save the lives of patients and retain their fertility at the same time as far as possible. The MTX and mifepristone combined with abortion is an effective treatment method for cervical pregnancy.

表1 3组宫颈妊娠患者一般临床资料比较(±s)
表2 3组宫颈妊娠患者疗效比较(±s)
[1]
Hirakawa M, Tajima T, Yoshimitsu K, et al. Uterine artery embolization along with the administration of methotrexate for cervical ectopic pregnancy: technical and clinical outcomes[J]. AJR Am J Roentgenol, 2009, 192(6): 1601-1607.
[2]
张惜阴. 实用妇产科学. 2版[M ]. 北京: 人民卫生出版社,2004: 174.
[3]
姚红丽. 宫颈妊娠诊治进展[J]. 现代实用医学,2013, 25(8): 958-960.
[4]
Heer JS, Chao DK, McPheeters RA. Cervical ectopic pregnancy[J]. West J Emerg Med, 2012, 13(1): 125-126.
[5]
效小莉,宋茜. 异位妊娠发病因素的相关分析[J/CD]. 中华妇幼临床医学杂志:电子版,2010, 6(2): 110-112.
[6]
Kung FT, Chang SY. Efficacy of methotrexate treatment in viable and nonviable cervical pregnancies[J]. Am J Obstet Gynecol, 1999, 181(6): 1438-1444.
[7]
Yu B, Douglas NC, Guarnaccia MM, et al. Uterine artery embolization as an adjunctive measure to decrease blood loss prior to evacuating a cervical pregnancy[J]. Arch Gynecol Obstet, 2009, 279(5): 721-724.
[8]
Nadisauskiene R, Vaicekavicius E, Taraseviciene V, et al. Conservative treatment of cervical pregnancy with selective unilateral uterine artery embolization[J]. Medicina (Kaunas), 2007, 43(11): 883-886.
[9]
Murji A, Garbedian K, Thomas J, et al. Conservative management of cervical ectopic pregnancy[J]. J Obstet Gynaecol Can, 2015, 37(11): 1016-1020.
[10]
Polak G, Stachowicz N, Morawska D, et al. Treatment of cervical pregnancy with systemic methotrexate and KCI solution injection into the gestational sac: case report and review of literature[J]. Ginekol Pol, 2011, 82(5): 386-389.
[11]
Jeng CJ, Ko ML, Shen J. Transvaginal ultrasound-guided treatment of cervical pregnancy[J]. Obstet Gynecol, 2007, 109(5): 1076-1082.
[12]
王丽先. 特殊类型异位妊娠5例[J/CD]. 中华妇幼临床医学杂志:电子版,2012, 8(5): 677.
[13]
Arowojolu AO, Ogunbode OO. Cervical ectopic pregnancy managed with methotrexate and tranexamic acid: a case report[J]. Afr J Med Med Sci, 2014, 43(4): 361-364.
[14]
Hosni MM, Herath RP, Mumtaz R. Diagnostic and therapeutic dilemmas of cervical ectopic pregnancy[J]. Obstet Gynecol Surv, 2014, 69(5): 261-276.
[15]
Song MJ, Moon MH, Kim JA, et al. Serial transvaginal sonographic findings of cervical ectopic pregnancy treated with high-dose methotrexate[J]. J Ultrasound Med, 2009, 28(1): 55-61.
[16]
Chaudhary V, Sachdeva P, Kumar D, et al. Conservative management of cervical pregnancy: a report of two cases[J]. J Reprod Med, 2013, 58(9-10): 451-457.
[17]
Gómez García MT, Aguarón BG, Barberá BB, et al. Medical therapy (methotrexate and mifepristone) alone or in combination with another type of therapy for the management of cervical or interstitial ectopic pregnancy[J]. Eur J Obstet Gynecol Reprod Biol, 2012, 165(1): 77-81.
[1] 赵旻暐, 耿霄, 褚红玲, 詹思延, 黄伟, 田华, 王坤正. 膝关节置换3D打印个性化手术工具临床应用专家共识计划书[J/OL]. 中华关节外科杂志(电子版), 2023, 17(03): 308-310.
[2] 袁涛, 钱洪, 杨少强, 赖圳登, 孟嘉, 江辉, 赵建宁, 包倪荣. 关节镜下全内缝合技术治疗冈上肌肌腱关节面撕裂[J/OL]. 中华关节外科杂志(电子版), 2022, 16(05): 611-615.
[3] 张佳, 李春宝, 安明扬, 吴毅东, 于康康, 刘玉杰. 临界型发育性髋关节发育不良的诊疗专家共识计划书[J/OL]. 中华关节外科杂志(电子版), 2022, 16(04): 394-398.
[4] 贺媛媛, 李佳, 杨红. 宫颈中肾腺癌1例并文献复习[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(01): 97-104.
[5] 曾舒涵, 庾楠楠, 应道静, 陈丽植, 容丽萍, 莫樱, 蒋小云. 激素敏感型原发性肾病综合征患儿激素治疗巩固维持阶段不同减量方案比较[J/OL]. 中华妇幼临床医学杂志(电子版), 2022, 18(04): 468-475.
[6] 袁传杰, 杨雪, 朱渝. 内脏利什曼病临床药物治疗研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2022, 18(04): 387-392.
[7] 李涛, 杨义, 冯光, 郝岱峰. 北京市某三甲医院创面修复专科病区5年间糖尿病足住院病例回顾性分析[J/OL]. 中华损伤与修复杂志(电子版), 2022, 17(05): 405-410.
[8] 王刚, 单伟根, 刘娟, 李长庆, 王新民. 常规治疗联合阿托伐他丁钙片对支气管扩张症临床分析[J/OL]. 中华肺部疾病杂志(电子版), 2023, 16(04): 538-540.
[9] 赵海林, 王璐璐, 罗冬冬, 胡骕, 李丹, 彭彪. 脑室-腹腔分流术对脑膜转移癌的治疗效果分析[J/OL]. 中华神经创伤外科电子杂志, 2022, 08(06): 335-340.
[10] 韦强, 秦赢, 王光明, 周立祥, 付双林, 栾永昕. 腰大池-腹腔分流术治疗交通性脑积水的临床疗效分析[J/OL]. 中华神经创伤外科电子杂志, 2022, 08(03): 173-177.
[11] 王帅, 王素平, 宋涛. 富血小板血浆在肩袖损伤治疗中的研究进展[J/OL]. 中华老年骨科与康复电子杂志, 2022, 08(06): 374-379.
[12] 贾春娟, 房贤村, 刘云霞, 吴华清. 自拟中药方剂(血安胃康)联合西药治疗上消化道出血的临床研究[J/OL]. 中华消化病与影像杂志(电子版), 2022, 12(01): 26-29.
[13] 袁捷, 乔钰琪, 李彦冬. 二甲双胍、来曲唑联合地屈孕酮治疗多囊卵巢综合征合并不孕症的效果评价[J/OL]. 中华临床医师杂志(电子版), 2024, 18(04): 343-347.
[14] 李瑞雨, 肖凌勇, 张悦欣, 励志英, 戴晓矞. 浅析醒脑开窍针刺法治疗缺血性脑卒中肢体功能障碍针刺时机研究的思路构建与方案设计[J/OL]. 中华针灸电子杂志, 2023, 12(04): 156-160.
[15] 汪赓, 夏泽锋, 陶凯雄. 代谢手术在非肥胖型2型糖尿病中的治疗效果及研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2023, 09(03): 155-160.
阅读次数
全文


摘要